Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 22;43(3):462-465.
doi: 10.1093/pubmed/fdaa241.

Association of substance use disorders and drug overdose with adverse COVID-19 outcomes in New York City: January-October 2020

Bennett Allen  1 , Omar El Shahawy  2 , Erin S Rogers  2   3 , Sarah Hochman  4   5 , Maria R Khan  1   2   6 , Noa Krawczyk  1
Affiliations

Association of substance use disorders and drug overdose with adverse COVID-19 outcomes in New York City: January-October 2020

Bennett Allen et al. J Public Health (Oxf). .

Abstract

Background: Evidence suggests that individuals with history of substance use disorder (SUD) are at increased risk of COVID-19, but little is known about relationships between SUDs, overdose and COVID-19 severity and mortality. This study investigated risks of severe COVID-19 among patients with SUDs.

Methods: We conducted a retrospective review of data from a hospital system in New York City. Patient records from 1 January to 26 October 2020 were included. We assessed positive COVID-19 tests, hospitalizations, intensive care unit (ICU) admissions and death. Descriptive statistics and bivariable analyses compared the prevalence of COVID-19 by baseline characteristics. Logistic regression estimated unadjusted and sex-, age-, race- and comorbidity-adjusted odds ratios (AORs) for associations between SUD history, overdose history and outcomes.

Results: Of patients tested for COVID-19 (n = 188 653), 2.7% (n = 5107) had any history of SUD. Associations with hospitalization [AORs (95% confidence interval)] ranged from 1.78 (0.85-3.74) for cocaine use disorder (COUD) to 6.68 (4.33-10.33) for alcohol use disorder. Associations with ICU admission ranged from 0.57 (0.17-1.93) for COUD to 5.00 (3.02-8.30) for overdose. Associations with death ranged from 0.64 (0.14-2.84) for COUD to 3.03 (1.70-5.43) for overdose.

Discussion: Patients with histories of SUD and drug overdose may be at elevated risk of adverse COVID-19 outcomes.

Keywords: COVID-19; drug overdose; substance use disorder.

PubMed Disclaimer

References

    1. Metzl JM, Maybank A, De Maio F. Responding to the COVID-19 pandemic: the need for a structurally competent health care system. JAMA 2020;324(3):231–2. - PubMed
    1. Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Intern Med 2020 Jul 7;173(1):61–2. - PMC - PubMed
    1. Wang QQ, Kaelber DC, Xu R et al. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry 2020;1–10. - PMC - PubMed
    1. Vallecillo G, Perelló R, Güerri R et al. Clinical impact of COVID-19 on people with substance use disorders. J Public Health 2020. - PMC - PubMed
    1. Ahmad FB, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics 2020.

Publication types